(Q69373474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

J Lappalainen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

J Hietala

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

E Syvälahti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

472-475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2570432%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00441944

1 October 2019

exact match

0 references

cites work

5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain

1 reference

12 December 2020

Catalepsy induced by SCH 23390 in rats

1 reference

12 December 2020

Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist

1 reference

12 December 2020

Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

1 reference

12 December 2020

Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

1 reference

12 December 2020

Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity

1 reference

12 December 2020

Tolerance to behavioral effects of haloperidol

1 reference

12 December 2020

D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].

1 reference

12 December 2020

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

12 December 2020

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions

1 reference

12 December 2020

Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

1 reference

12 December 2020

Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.

1 reference

12 December 2020

[3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus

1 reference

12 December 2020

Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics

1 reference

12 December 2020

Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats

1 reference

12 December 2020

Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus

1 reference

12 December 2020

Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

1 reference

12 December 2020

SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors.

1 reference

12 December 2020

Tolerance of haloperidol catalepsy

1 reference

12 December 2020

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

1 reference

12 December 2020

Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020